Scarica l'app Stockscreener
2.39
17.87%
-0.52
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
60 Degrees Pharmaceuticals, Inc. Files Updated Legal Opinion for ATM Equity Offering Program – March 2026 - Minichart
60 Degrees Pharmaceuticals files updated legal opinion for ATM equity program - Investing.com Australia
60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering - TipRanks
60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity - TradingView
60 Degrees (SXTP) updates ATM capacity to $565K after prior sales - Stock Titan
What's Going On With 60 Degrees Pharmaceuticals On Friday? - Benzinga
Quarterly Risk: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Files Form 8-K With NASDAQ Listing Details and Corporate Information - Minichart
60 Degrees Pharmaceuticals files updated legal opinion for at-the-market offering - Investing.com
60 Degrees Pharmaceuticals Updates Opinion for ATM Program - TipRanks
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
60 Degrees Pharma flies after curing tick disease in small-scale study - Mugglehead Investment Magazine
60 Degrees reports babesiosis cure in three trial patients - Investing.com India
60 Degrees reports babesiosis cure in three trial patients By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
SXTP Stock Dips Amid Earnings Shake: Investors On Edge - timothysykes.com
In tiny trial, malaria drug combo cleared a stubborn tick-borne infection - Stock Titan
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Panama City News Herald
Big Picture: What are analysts price targets for 60 Degrees Pharmaceuticals Inc Equity WarrantJuly 2025 Snapshot & Long-Term Capital Growth Ideas - baoquankhu1.vn
How interest rate cuts could boost 60 Degrees Pharmaceuticals Inc. stockTake Profit & AI Enhanced Execution Alerts - Naître et grandir
Earnings Update: Whats the fair value of 60 Degrees Pharmaceuticals Inc stock2025 Sector Review & Risk Managed Investment Strategies - baoquankhu1.vn
Short Squeeze: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising rates2025 Geopolitical Influence & AI Forecasted Stock Moves - baoquankhu1.vn
SXTP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SXTPW SEC Filings60 Degrees Pharm 10-K, 10-Q, 8-K Forms - Stock Titan
[424B5] 60 DEGREES PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan
Movement Recap: Should I trade or invest in 60 Degrees Pharmaceuticals Inc Equity Warrant2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Palm Beach Daily News
SXTP PE Ratio & Valuation, Is SXTP Overvalued - Intellectia AI
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Aug Summary: How is 60 Degrees Pharmaceuticals Inc managing supply chain issuesMarket Growth Report & Consistent Growth Stock Picks - baoquankhu1.vn
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA - Finviz
Forecast Cut: Is 60 Degrees Pharmaceuticals Inc stock technically oversold - baoquankhu1.vn
10 Best Up and Coming Penny Stocks to Buy - Insider Monkey
Rafael (NYSE:RFL) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP) Compared - National Today
SXTP60 degrees pharmaceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
Aug Movers: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major indexTrade Ideas & Verified Swing Trading Watchlist - baoquankhu1.vn
What’s the outlook for 60 Degrees Pharmaceuticals Inc. Equity Warrant’s sectorWeekly Profit Analysis & Reliable Breakout Forecasts - mfd.ru
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Asheville Citizen Times
Can 60 Degrees Pharmaceuticals Inc. stock double in next 5 yearsMarket Risk Analysis & High Accuracy Trade Alerts - mfd.ru
Analyzing Rafael (NYSE:RFL) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
Pullback Watch: Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a top pick in the sector2025 Buyback Activity & Daily Entry Point Trade Alerts - mfd.ru
Will 60 Degrees Pharmaceuticals Inc. benefit from sector rotationMarket Sentiment Report & Technical Confirmation Trade Alerts - mfd.ru
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from geopolitical trendsMarket Performance Recap & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Trade Recap: How sensitive is 60 Degrees Pharmaceuticals Inc to inflation2025 Analyst Calls & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Dip Buying: Can 60 Degrees Pharmaceuticals Inc Equity Warrant maintain sales growthDay Trade & Real-Time Volume Triggers - baoquankhu1.vn
Will 60 Degrees Pharmaceuticals Inc. outperform its industry peersTake Profit & Short-Term Swing Trade Alerts - mfd.ru
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant grow without external funding2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - mfd.ru
Why 60 Degrees Pharmaceuticals Inc. stock could outperform in 2025July 2025 EndofMonth & Weekly Return Optimization Plans - mfd.ru
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock is a must watch in 2025Market Activity Report & Verified Trade Idea Suggestions - mfd.ru
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant maintain sales growthEarnings Recap Report & Risk Managed Investment Strategies - mfd.ru
SXTP Technical Analysis & Stock Price Forecast - Intellectia AI
Can 60 Degrees Pharmaceuticals Inc. stock sustain revenue growthJuly 2025 Setups & Safe Entry Momentum Tips - mfd.ru
60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status - The Globe and Mail
60 Degrees Pharmaceuticals company regained compliance with Nasdaq minimum bid price - marketscreener.com
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):